Mar 2018

NATIONAL EVIDENCE REVIEW RELEASED

The Commonwealth Department of Health, in conjunction with state and territory governments, has helped coordinate the development of new clinical guidance documents for medicinal cannabis products. It includes a national review of the scientific evidence for the use of cannabis medicines in five areas: palliative care, nausea and vomiting, epilepsy, multiple sclerosis and pain.

More information is available on the TGA website and can be found here.

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

In an exclusive interview with 60 Minutes, Olivia Newton-John, Australian actress who is recovering from her third breast cancer continues to credit medical cannabis with helping her manage not only the pain, but also sleep and anxiety.

READ MORE >

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >